Page 1 of 92
MIDTERM EXAM: NR566 / NR 566 FNP (LATEST UPDATE
2025) ADVANCED PHARMACOLOGY FOR CARE OF THE
FAMILY | QUESTIONS & ANSWERS | 100% CORRECT |
GRADE A - CHAMBERLAIN
Albuterol .....ANSWER.....-increases levels of digoxin
-safe if children
-first line therapy
Etidronate (Didronel) .....ANSWER.....Bisphosphonates
-90 day half life
-preg cat B
reduces bone reabsorption
TX: low bone density, d/t cystic fibrosis, pagets disease (monitor
xrays and labs), heterotropic ossification, hip replacement, spinal
cord injury
CI: entercolitis
,Page 2 of 92
Alendeonate (fosamax) .....ANSWER.....Biphosphonates
-10 yr. half life
( $cheapest)
TX: osteoporosis men, postmenopausal women, gluccorticoids
induced, pagets diseae
bioavailability of biphosphonates .....ANSWER.....histamine 2
blocking, ranitadine agents double ALENDRONATE
TILUDRONATE decrease 50 % by aspirin and is increased by
INDOMENTHACIN *consider each nsaid individually
Anastozole, letroxole, exemestane .....ANSWER.....aromatase
inhibitors
*hormone therapy to tx hormone receptor positive breast cancer.
AE: vertigo, insomnia, sleepiness, confusion, LIFE THREATENING
BLOOD CLOTTING, LOSS BONE MASS,
*take Ca+ vit D supplementation
,Page 3 of 92
*measure bone density
GH (somatotropin) .....ANSWER.....*used in children with GH
deficiency treats hypoglycemia
Biophosphanates pt education .....ANSWER.....*empty stomach 8
oz water
avoid anitacids/ alcohol
ETIDRONATE increase in fx with pagets disease monitor labs and
xrays
drugs associated with bone loss that should be monitored
.....ANSWER.....aromatase inhibitors, thyroid hormones,
gluccocorticoid, PPI, SSRI
Antidiabetic mediations to avoid in elderly
.....ANSWER.....Sulfonylureas -hypoglycemia
Glimpride
Glyburide- most likely to cause hypo
, Page 4 of 92
metformin *renal insuffiency HF
Alpha-glycosidase inhibitors- not well tolerated
Screening of Type 2 DM .....ANSWER.....>45 yrs old BMI >25
*test yearly
>45 yrs old BMI WNL *q 3 yrs
<45 yrs old VMI >25* test more frequent.
Lispro, Aspart, Glulisine .....ANSWER.....rapid acting insulin
15 min peak 1 hr duration
Regular insulin
Regular U -500 .....ANSWER.....short acting insulin * used as bolus
to correct hyperglycemia
Regular insulin onset 30-60- peak 2-3 dura. 3-7
U-500 onset 30-45, peak 2-4, duration 8-24 hr
MIDTERM EXAM: NR566 / NR 566 FNP (LATEST UPDATE
2025) ADVANCED PHARMACOLOGY FOR CARE OF THE
FAMILY | QUESTIONS & ANSWERS | 100% CORRECT |
GRADE A - CHAMBERLAIN
Albuterol .....ANSWER.....-increases levels of digoxin
-safe if children
-first line therapy
Etidronate (Didronel) .....ANSWER.....Bisphosphonates
-90 day half life
-preg cat B
reduces bone reabsorption
TX: low bone density, d/t cystic fibrosis, pagets disease (monitor
xrays and labs), heterotropic ossification, hip replacement, spinal
cord injury
CI: entercolitis
,Page 2 of 92
Alendeonate (fosamax) .....ANSWER.....Biphosphonates
-10 yr. half life
( $cheapest)
TX: osteoporosis men, postmenopausal women, gluccorticoids
induced, pagets diseae
bioavailability of biphosphonates .....ANSWER.....histamine 2
blocking, ranitadine agents double ALENDRONATE
TILUDRONATE decrease 50 % by aspirin and is increased by
INDOMENTHACIN *consider each nsaid individually
Anastozole, letroxole, exemestane .....ANSWER.....aromatase
inhibitors
*hormone therapy to tx hormone receptor positive breast cancer.
AE: vertigo, insomnia, sleepiness, confusion, LIFE THREATENING
BLOOD CLOTTING, LOSS BONE MASS,
*take Ca+ vit D supplementation
,Page 3 of 92
*measure bone density
GH (somatotropin) .....ANSWER.....*used in children with GH
deficiency treats hypoglycemia
Biophosphanates pt education .....ANSWER.....*empty stomach 8
oz water
avoid anitacids/ alcohol
ETIDRONATE increase in fx with pagets disease monitor labs and
xrays
drugs associated with bone loss that should be monitored
.....ANSWER.....aromatase inhibitors, thyroid hormones,
gluccocorticoid, PPI, SSRI
Antidiabetic mediations to avoid in elderly
.....ANSWER.....Sulfonylureas -hypoglycemia
Glimpride
Glyburide- most likely to cause hypo
, Page 4 of 92
metformin *renal insuffiency HF
Alpha-glycosidase inhibitors- not well tolerated
Screening of Type 2 DM .....ANSWER.....>45 yrs old BMI >25
*test yearly
>45 yrs old BMI WNL *q 3 yrs
<45 yrs old VMI >25* test more frequent.
Lispro, Aspart, Glulisine .....ANSWER.....rapid acting insulin
15 min peak 1 hr duration
Regular insulin
Regular U -500 .....ANSWER.....short acting insulin * used as bolus
to correct hyperglycemia
Regular insulin onset 30-60- peak 2-3 dura. 3-7
U-500 onset 30-45, peak 2-4, duration 8-24 hr
